Weisman Harlan F
- SEC CIK
- 0001555563
No open-market purchases or sales filed in the past year.
Current role at each company
- TFFP TFF Pharmaceuticals, Inc.President and CEOas of Jul 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Weisman Harlan F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Weisman Harlan FPresident and CEO | PPurchase | +600.0K | $0.25 | +$150.0K | +279.6%814.6K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Weisman Harlan FPresident and CEO | PPurchase | +150.0K | $0.88 | +$132.0K | +232.1%214.6K after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Weisman Harlan FPresident and CEO | PPurchase | +50.0K | $1.06 | +$53.0K | +342.1%64.6K after | |
| May 20, 2022 (view filing) | May 18-20 | 2 days | Weisman Harlan FDirector | PPurchase | +7.12K | $5.37 | +$38.2K | +94.9%14.6K after | 2 lots |
| May 17, 2022 (view filing) | May 16 | 1 day | Weisman Harlan FDirector | PPurchase | +2.50K | $4.74 | +$11.8K | +50.0%7.50K after |